- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04872712
Comparing Press and Filiform Needle Acupuncture Effectiveness for Improving Insomnia in COVID-19 Healthcare Workers
Comparison of the Effectiveness of Manual Acupuncture Therapy Between Press Needle and Filiform Needle for Symptoms of Insomnia and Melatonin Hormone Serum on COVID-19 Frontline Health Workers at RSCM.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Cipto Mangunkusumo hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Health care workers treating COVID-19 patients in Cipto Mangunkusumo Hospital.
- Has Symptoms of insomnia for at least 2 weeks (screened using the PHQ-9 instrument modified to question number 3a with an answer score of at least 1)
- Age 20 - 50 years.
- Has negative COVID-19 rapid test or PCR swab result in the 7 days prior to the study.
- Willing to participate in research by signing an informed consent.
- Willing to follow the research process to completion.
Exclusion Criteria:
- If you answered Yes to PHQ-9 number 3a never or 3b with a yes
- Insomnia is caused by moderate pain (with Numeric Rating Scale > 4)
- Insomnia patients with medical therapy such as benzodiazepines, non-benzodiazepines, melatonin drugs and antidepressants
- Has severe social and occupational dysfunction (with the Global Assessment of Functioning < 50).
- Has a history of contraindications to acupuncture such as medical emergencies, pregnancy, thrombocytopenia with a platelet count below 50,000 per microliter of blood, history of blood clotting disorders / taking blood thinners, puncturing over malignant tumors, or infection or scarring in the acupuncture area.
- The patient is febrile with a temperature more than 38 Celsius
- Have had acupuncture in the last 7 days prior to study.
- No limbs
- Cognitive impairments or impaired consciousness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Press Needles
The subjects/population of this study is Health Workers with insomnia symptoms who work at at Cipto Mangunkusumo Hospital treating COVID-19 patients.
Subjects group with Press Needles treatment will be treated with 2-week needle retention, 20-second pressing 3 times a day and needle replacement performed every 5 days.
The needles are inserted 0.9 mm deep at the acupuncture points HT7 Shenmen, PC6 Neiguan, ST36 Zusanli and SP6 Sanyinjiao.
|
Manual acupuncture using press needles
|
|
Active Comparator: Filiform Needles
The subjects/population of this study is Health Workers with insomnia symptoms who work at at Cipto Mangunkusumo Hospital treating COVID-19 patients.
Subjects group with filiform needles treatment will be treated with 20-minute needle retention, 3 times a week for 2 weeks (total of 6 therapy sessions).
The needles are inserted approximately 12 mm deep at the acupuncture points HT7 Shenmen and PC6 Neiguan and 25 mm deep at the ST36 Zusanli and SP6 Sanyinjiao.
|
Manual acupuncture using filiform needles
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pittsburgh Sleep Quality Index (PSQI) Questionnaire Score
Time Frame: 6 weeks (4 times measurement : Before the treatment and every 2 weeks until week 6)
|
Pittsburgh Sleep Quality Index (PSQI) Questionnaire used have 19 questions related to sleep quality and disturbances, grouped into seven-component scores. The seven components of the score were then summed to produce the global PSQI score, which has a range from 0 as minimum and 21 as maximum score. Higher Total PSQI score indicates poorer sleep quality. The PSQI score was measured at 4 time points per subject (Before the treatment and every 2 weeks until week 6) to understand the change and impact before and after the treatment as well as the lasting effect within 4 weeks of treatment was finished. |
6 weeks (4 times measurement : Before the treatment and every 2 weeks until week 6)
|
|
Change in Melatonin Level via Blood Test
Time Frame: 2 weeks ( 2 times measurement : Before the treatment and after the treatment is completed (treatment duration: 2 weeks)
|
Melatonin Level was measured through blood sampling and test to determine the level of melatonin (in pg/mL) in the human serum. The higher the Melatonin Level indicates better outcome. The Melatonin Level was measured 2 times for all subjects (Before and after the treatment which is in span of 2 weeks) to understand the change and impact before and after the treatment. |
2 weeks ( 2 times measurement : Before the treatment and after the treatment is completed (treatment duration: 2 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Irma Nareswari, dr. Sp.Ak, Fakultas Kedokteran Universitas Indonesia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-02-0142
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteRecruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
Shanghai Haiyan Pharmaceutical Technology Co.,...Completed
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
Clinical Trials on Press needles
-
Indonesia UniversityRecruitingTuberculosis, PulmonaryIndonesia
-
Chang Gung Memorial HospitalCompleted
-
Indonesia UniversityRecruitingPost-operative Pain | Spine, OpenIndonesia
-
Nihat SarıalioğluCompletedResistance Training | Muscle Mechanical PropertiesTurkey (Türkiye)
-
Cairo UniversityCompletedTooth Discoloration | FractureEgypt
-
Rambam Health Care CampusCompleted
-
Indonesia UniversityCompletedChronic Pain | Depressive SymptomsIndonesia
-
University of Medicine and Pharmacy at Ho Chi Minh...RecruitingPost-stroke Depression | Insomnia, SecondaryVietnam
-
Aarhus University Hospital SkejbyRingkjøbing County Research Fond; Union of Midwives Research Fond; Skejby Research...CompletedPregnancy Overdue - Week 41+6
-
Cairo UniversityRecruiting